| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 30.92B | 37.82B | 31.61B | 25.26B | 20.04B | 17.02B |
| Gross Profit | 12.64B | 15.32B | 12.19B | 8.99B | 7.60B | 5.29B |
| EBITDA | 6.90B | 5.42B | 4.06B | 3.12B | 1.62B | -7.36B |
| Net Income | 4.69B | 3.81B | 3.28B | 3.15B | 605.38M | -7.56B |
Balance Sheet | ||||||
| Total Assets | 50.24B | 50.01B | 47.70B | 38.82B | 33.14B | 31.77B |
| Cash, Cash Equivalents and Short-Term Investments | 22.41B | 17.50B | 12.58B | 13.71B | 14.26B | 12.49B |
| Total Debt | 9.45B | 10.86B | 11.09B | 4.35B | 5.06B | 4.51B |
| Total Liabilities | 15.11B | 17.98B | 19.04B | 11.65B | 9.97B | 9.66B |
| Stockholders Equity | 35.13B | 32.03B | 28.66B | 27.16B | 23.17B | 22.11B |
Cash Flow | ||||||
| Free Cash Flow | 6.05B | 7.20B | -5.85B | -1.38B | 1.08B | -1.27B |
| Operating Cash Flow | 6.89B | 7.64B | -4.93B | -799.70M | 1.33B | -843.54M |
| Investing Cash Flow | 2.28B | -390.29M | -402.68M | 522.05M | -255.80M | -34.54M |
| Financing Cash Flow | -3.14B | -2.79B | 4.12B | -1.42B | 397.94M | 3.99B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥30.53B | 4.13 | ― | 4.54% | -20.75% | 7.75% | |
78 Outperform | ¥256.31B | 8.98 | ― | 3.99% | 6.02% | 18.88% | |
76 Outperform | ¥780.30B | 8.32 | 7.77% | 3.16% | 4.30% | 78.29% | |
73 Outperform | ¥796.41B | 18.04 | 10.50% | 2.03% | 5.40% | 23.70% | |
71 Outperform | ¥782.48B | 8.78 | 6.04% | 2.78% | 4.46% | 70.22% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
47 Neutral | ¥282.91B | -71.33 | -12.69% | 0.71% | -11.22% | -731.07% |